These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29865877)

  • 1. New paradigm for rapid achievement of appropriate therapy in special populations: coupling antibiotic dose optimization rapid microbiological methods.
    Abdul-Aziz MH; Driver E; Lipman J; Roberts JA
    Expert Opin Drug Metab Toxicol; 2018 Jul; 14(7):693-708. PubMed ID: 29865877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of dosing regimens and dosing in special populations.
    Sime FB; Roberts MS; Roberts JA
    Clin Microbiol Infect; 2015 Oct; 21(10):886-93. PubMed ID: 25980350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?
    Jamal JA; Mueller BA; Choi GY; Lipman J; Roberts JA
    Diagn Microbiol Infect Dis; 2015 May; 82(1):92-103. PubMed ID: 25698632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use and risks of antibiotics in critically ill patients.
    Denny KJ; Cotta MO; Parker SL; Roberts JA; Lipman J
    Expert Opin Drug Saf; 2016 May; 15(5):667-78. PubMed ID: 26961691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing dosing of antibiotics in critically ill patients.
    Parker SL; Sime FB; Roberts JA
    Curr Opin Infect Dis; 2015 Dec; 28(6):497-504. PubMed ID: 26382000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic aspects of beta-lactam antibiotic therapy in intensive care unit patients: A one-center experience with TDM.
    Sadilová K; Halačová M; Černý D
    Ceska Slov Farm; 2020; 69(1):17-23. PubMed ID: 32460506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic dosing for multidrug-resistant pathogen pneumonia.
    Abdul-Aziz MH; Lipman J; Roberts JA
    Curr Opin Infect Dis; 2017 Apr; 30(2):231-239. PubMed ID: 28030371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of continuous renal replacement therapy on antibiotic pharmacokinetics in critically ill patients.
    Fiore M; Peluso L; Taccone FS; Hites M
    Expert Opin Drug Metab Toxicol; 2021 May; 17(5):543-554. PubMed ID: 33733979
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections.
    Tängdén T; Ramos Martín V; Felton TW; Nielsen EI; Marchand S; Brüggemann RJ; Bulitta JB; Bassetti M; Theuretzbacher U; Tsuji BT; Wareham DW; Friberg LE; De Waele JJ; Tam VH; Roberts JA;
    Intensive Care Med; 2017 Jul; 43(7):1021-1032. PubMed ID: 28409203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Guidance for Antibiotic Dosing in Obese Adults.
    Meng L; Mui E; Holubar MK; Deresinski SC
    Pharmacotherapy; 2017 Nov; 37(11):1415-1431. PubMed ID: 28869666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right Dose, Right Now: Customized Drug Dosing in the Critically Ill.
    Roberts JA; Kumar A; Lipman J
    Crit Care Med; 2017 Feb; 45(2):331-336. PubMed ID: 28098629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of the pharmacokinetic/pharmacodynamic (PK/PD) analysis of antimicrobial agents.
    Asín-Prieto E; Rodríguez-Gascón A; Isla A
    J Infect Chemother; 2015 May; 21(5):319-29. PubMed ID: 25737147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic exposure at the site of infection: principles and assessment of tissue penetration.
    Jager NGL; van Hest RM; Lipman J; Roberts JA; Cotta MO
    Expert Rev Clin Pharmacol; 2019 Jul; 12(7):623-634. PubMed ID: 31136211
    [No Abstract]   [Full Text] [Related]  

  • 14. Population pharmacokinetics and dosing simulations of cefuroxime in critically ill patients: non-standard dosing approaches are required to achieve therapeutic exposures.
    Carlier M; Noë M; Roberts JA; Stove V; Verstraete AG; Lipman J; De Waele JJ
    J Antimicrob Chemother; 2014 Oct; 69(10):2797-803. PubMed ID: 24917580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainty in Antibiotic Dosing in Critically Ill Neonate and Pediatric Patients: Can Microsampling Provide the Answers?
    Dorofaeff T; Bandini RM; Lipman J; Ballot DE; Roberts JA; Parker SL
    Clin Ther; 2016 Sep; 38(9):1961-75. PubMed ID: 27544661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic dose optimization in critically ill patients.
    Cotta MO; Roberts JA; Lipman J
    Med Intensiva; 2015 Dec; 39(9):563-72. PubMed ID: 26415688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically relevant pharmacokinetic knowledge on antibiotic dosing among intensive care professionals is insufficient: a cross-sectional study.
    Fleuren LM; Roggeveen LF; Guo T; Waldauf P; van der Voort PHJ; Bosman RJ; Swart EL; Girbes ARJ; Elbers PWG
    Crit Care; 2019 May; 23(1):185. PubMed ID: 31118061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimisation of antimicrobial dosing based on pharmacokinetic and pharmacodynamic principles.
    Hoo GSR; Liew YX; Kwa AL
    Indian J Med Microbiol; 2017; 35(3):340-346. PubMed ID: 29063877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the introduction of real-time therapeutic drug monitoring on empirical doses of carbapenems in critically ill burn patients.
    Fournier A; Eggimann P; Pagani JL; Revelly JP; Decosterd LA; Marchetti O; Pannatier A; Voirol P; Que YA
    Burns; 2015 Aug; 41(5):956-68. PubMed ID: 25678084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development.
    Abdul-Aziz MH; Lipman J; Mouton JW; Hope WW; Roberts JA
    Semin Respir Crit Care Med; 2015 Feb; 36(1):136-53. PubMed ID: 25643277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.